Through the transaction, Aurobindo USA will expand its product portfolio in this segment while gaining a U.S.-based manufacturing facility
Veteran health innovation and policy leader to drive biotechnology innovation, startup growth and commercialization of indigenous technologies
The sale is part of a broader strategy to streamline its asset footprint and concentrate investment on core growth areas
The company will now distribute American Distilling’s range of natural specialty ingredients for use in cosmetics, personal care, and pharmaceutical applications across select EMEA markets
The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections
The collaboration is focused on overcoming a major limitation in existing cancer drugs
Company becomes sole first applicant for 45 mg strength, positioning itself for potential 180-day generic exclusivity in the US market
State-of-the-art facility brings next-generation imaging and minimally invasive neurointerventional capabilities to Eastern India
New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones
Backs Lifesigns in first bet and doubles down on India’s healthcare AI surge
Subscribe To Our Newsletter & Stay Updated
